The Latest Analyst Ratings for Pfizer
Portfolio Pulse from Benzinga Insights
Pfizer (NYSE:PFE) has received various analyst ratings in the last quarter, with 3 bullish, 6 somewhat bullish, and 4 indifferent. The average price target from these 13 analysts is $58.15, significantly higher than Pfizer's current price of $32.96. This target has increased by 25.95% over the past month.
October 02, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a bullish outlook on Pfizer, with a price target significantly higher than its current price. This could potentially drive the stock price up in the short term.
Analyst ratings are a key driver of stock prices. The bullish sentiment and high price target indicate a positive outlook for Pfizer, which could potentially drive its stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100